Press release
Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market Driver: Leading Transformation in the Intestine Cancer Therapeutics Market in 2025
Intestine Cancer Therapeutics Market
The rise in instances of hereditary colorectal cancer syndromes is anticipated to stoke the expansion of the intestine cancer therapeutics market. These syndromes constitute a variety of genetic disorders that enhance a person's susceptibility to colorectal cancer, which can occur in the colon or rectu*m. The integral part played by hereditary colorectal cancer syndromes in intestine cancer therapeutics emerges from the insights they offer about specific genetic mutations considerably boosting the chances of contracting colorectal cancer. For example, data from the World Health Organization, based in Switzerland, in July 2023 indicated that by 2040, hereditary colorectal cancer rates are set to surge markedly, with about 3.2 million fresh cases and 1.6 million deaths per year predicted. This means a jump of 63% in new cases and a 73% rise in deaths compared to the present levels, indicating that the growing occurrence of hereditary colorectal cancer syndromes is fuelling the intestine cancer therapeutics market's expansion. Intestine Cancer Therapeutics Market Driver: Transformation of Intestine Cancer Therapeutics Market through Personalized Medicine
Get Your Intestine Cancer Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report
How will the growth rate of the intestine cancer therapeutics market shape industry trends by 2034?
The market size for therapy methods for intestinal cancer has experienced robust growth in the past few years. It's projected to advance from $14 billion in 2024 to $15.26 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 9.0%. Factors that contributed to its growth during the historical period include developments in medical research, a rise in cancer cases, the application of chemotherapy and radiation therapies, initiatives for screening and early detection, as well as discoveries related to genetics and biomarkers.
It is anticipated that the market for intestine cancer therapeutics will experience robust growth in the coming years, increasing to a worth of $21.15 billion in 2029, expanding at an 8.5% Compound Annual Growth Rate (CAGR). Factors contributing to this growth over the forecast period include advances in immunotherapy, precision medicine and individualized treatments, the advent of targeted therapies, the utilization of artificial intelligence (AI), and patient-focused strategies. Significant trends to watch during the forecast period entail technologies like liquid biopsy, research in precision medicine and biomarkers, combination treatments, patient-oriented care and supplementary therapies, along with the adoption of less invasive surgical techniques.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13231&type=smp
What trends are poised to drive the future success of the intestine cancer therapeutics market?
Leading firms in the intestines cancer therapeutics sector are creating innovative drugs, like Lonsurf, and garnering approvals in order to expand their customer segments, drive sales up, and boost revenue. LONSURF is a dual-drug formula consisting of trifluridine and tipiracil, designed for the treatment of adults suffering from metastatic colorectal cancer. In August 2023, for instance, Taiho Oncology Inc., an American pharmaceutical company, secured approval for Lonsurf from the US Food and Drug Administration. Lonsurf is dispensed as a single oral tablet, where trifluridine functions by halting the proliferation of cancer cells, and tipiracil ensures the longevity of trifluridine's effectiveness by stopping it from being metabolised by the body prematurely. Consequently, the approval of Lonsurf offers metastatic colorectal cancer patients, and others eligible, a novel treatment alternative, potentially enhancing treatment successes and quality of life.
Which primary segments of the intestine cancer therapeutics market are driving growth and industry transformations?
The intestine cancer therapeutics market covered in this report is segmented -
1) By Treatment Type: Immunotherapy, Chemotherapy, Other Treatments
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Hospitals, Homecare, Specialty Centers, Other Applications
Subsegments:
1) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines
2) By Chemotherapy: Adjuvant Chemotherapy, Neoadjuvant Chemotherapy, Palliative Chemotherapy
3) By Other Treatments: Targeted Therapy, Radiation Therapy, Surgery, Hormone Therapy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13231
Which geographical regions are pioneering growth in the intestine cancer therapeutics market?
Asia-Pacific was the largest region in the intestine cancer therapeutics market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the intestine cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the intestine cancer therapeutics market landscape?
Major companies operating in the intestine cancer therapeutics market report are Pfizer Inc., Johnson & Johnson Private Limited, Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Cipla Inc., Aurobindo Pharma Limited, Lupin Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13231&type=smp
What Is Covered In The Intestine Cancer Therapeutics Global Market Report?
•Market Size Forecast: Examine the intestine cancer therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the intestine cancer therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the intestine cancer therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the intestine cancer therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the intestine cancer therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the intestine cancer therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the intestine cancer therapeutics market.
•Competitive Landscape: Review strategic developments in the intestine cancer therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market Driver: Leading Transformation in the Intestine Cancer Therapeutics Market in 2025 here
News-ID: 3914025 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
